| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | 30.204 | 14.456 | 9.271 | 8.108 | 4.347 | 2.948 | 37.065 | 76.177 | 1.197 |
| Total Income - EUR | - | 30.204 | 14.456 | 9.271 | 8.108 | 4.347 | 2.948 | 37.065 | 76.368 | 18.832 |
| Total Expenses - EUR | - | 11.608 | 11.019 | 5.083 | 4.538 | 3.786 | 3.618 | 7.576 | 18.434 | 33.085 |
| Gross Profit/Loss - EUR | - | 18.596 | 3.437 | 4.188 | 3.571 | 561 | -670 | 29.489 | 57.934 | -14.253 |
| Net Profit/Loss - EUR | - | 17.689 | 3.003 | 3.910 | 3.328 | 431 | -758 | 28.656 | 57.171 | -14.432 |
| Employees | - | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 1 |
Check the financial reports for the company - Iresearch Medical S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 17.620 | 14.437 |
| Current Assets | - | 21.094 | 9.918 | 10.559 | 10.741 | 1.009 | 386 | 28.754 | 66.363 | 1.436 |
| Inventories | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | - | 0 | 652 | 2.268 | 2.367 | 33 | 0 | 25.840 | 717 | 156 |
| Cash | - | 21.094 | 9.266 | 8.291 | 8.374 | 976 | 386 | 2.913 | 65.646 | 1.280 |
| Shareholders Funds | - | 17.734 | 3.047 | 3.953 | 3.370 | 472 | -297 | 28.358 | 67.249 | -7.869 |
| Social Capital | - | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | 3.360 | 6.871 | 6.606 | 7.371 | 536 | 682 | 395 | 16.734 | 23.742 |
| Income in Advance | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "7211 - 7211" | |||||||||
| CAEN Financial Year |
7211
|
|||||||||
Comments - Iresearch Medical S.r.l.